Medical News Today -- Two recent independent studies have confirmed that Agfa HealthCare’s pioneering DX-S offline detector system delivers high quality diagnostic exposures with significantly reduced patient exposure dose. A study by the University Clinical Center of Giessen and Marburg in Germany evaluated the dose and quality performance of Agfa HealthCare’s DX-S system, compared to the performance of a 400 speed class screen/film system. The study involved 200 thoracic exposures from children (1). The second study, by the Friedrich Schiller University in Jena, Germany, covered larger children and adolescents and exposures using a chest phantom (2). The results were evaluated by five investigators. Both studies concluded that with Agfa HealthCare’s DX-S system the dose could be reduced by up to 50 percent, without reducing the diagnostic quality.
